Cargando…
Epigenetic Reprogramming of the Inflammatory Response in Obesity and Type 2 Diabetes
For the past several decades, the prevalence of obesity and type 2 diabetes (T2D) has continued to rise on a global level. The risk contributing to this pandemic implicates both genetic and environmental factors, which are functionally integrated by epigenetic mechanisms. While these conditions are...
Autores principales: | Zatterale, Federica, Raciti, Gregory Alexander, Prevenzano, Immacolata, Leone, Alessia, Campitelli, Michele, De Rosa, Veronica, Beguinot, Francesco, Parrillo, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313117/ https://www.ncbi.nlm.nih.gov/pubmed/35883538 http://dx.doi.org/10.3390/biom12070982 |
Ejemplares similares
-
The Transcription Factor HOXA5: Novel Insights into Metabolic Diseases and Adipose Tissue Dysfunction
por: Parrillo, Luca, et al.
Publicado: (2023) -
Methylglyoxal Impairs the Pro-Angiogenic Ability of Mouse Adipose-Derived Stem Cells (mADSCs) via a Senescence-Associated Mechanism
por: Leone, Alessia, et al.
Publicado: (2023) -
DNA Methylation and Type 2 Diabetes: Novel Biomarkers for Risk Assessment?
por: Raciti, Gregory Alexander, et al.
Publicado: (2021) -
Epigenetic silencing of the ANKRD26 gene correlates to the pro-inflammatory profile and increased cardio-metabolic risk factors in human obesity
por: Desiderio, Antonella, et al.
Publicado: (2019) -
Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications
por: Longo, Michele, et al.
Publicado: (2019)